Search Results - "THIBERT, RONALD L"

Refine Results
  1. 1

    Early and effective treatment of KCNQ2 encephalopathy by Pisano, Tiziana, Numis, Adam L., Heavin, Sinéad B., Weckhuysen, Sarah, Angriman, Marco, Suls, Arvid, Podesta, Barbara, Thibert, Ronald L., Shapiro, Kevin A., Guerrini, Renzo, Scheffer, Ingrid E., Marini, Carla, Cilio, Maria Roberta

    Published in Epilepsia (Copenhagen) (01-05-2015)
    “…Summary Objectives To describe the antiepileptic drug (AED) treatment of patients with early infantile epileptic encephalopathy due to KCNQ2 mutations during…”
    Get full text
    Journal Article
  2. 2

    A Quantitative Electrophysiological Biomarker of Duplication 15q11.2-q13.1 Syndrome by Frohlich, Joel, Senturk, Damla, Saravanapandian, Vidya, Golshani, Peyman, Reiter, Lawrence T, Sankar, Raman, Thibert, Ronald L, DiStefano, Charlotte, Huberty, Scott, Cook, Edwin H, Jeste, Shafali S

    Published in PloS one (15-12-2016)
    “…Duplications of 15q11.2-q13.1 (Dup15q syndrome) are highly penetrant for autism spectrum disorder (ASD). A distinct electrophysiological (EEG) pattern…”
    Get full text
    Journal Article
  3. 3

    Angelman syndrome in adolescence and adulthood: A retrospective chart review of 53 cases by Prasad, Ankita, Grocott, Olivia, Parkin, Kimberly, Larson, Anna, Thibert, Ronald L.

    “…Angelman syndrome is a neurogenetic disorder with varying clinical presentations and symptoms as the individual ages. The goal of this study was to…”
    Get full text
    Journal Article
  4. 4

    Neurologic Manifestations of Angelman Syndrome by Thibert, Ronald L., DO, MsPH, Larson, Anna M., BA, Hsieh, David T., MD, Raby, Annabel R, Thiele, Elizabeth A., MD, PhD

    Published in Pediatric neurology (01-04-2013)
    “…Abstract Angelman syndrome is a neurogenetic disorder characterized by the loss or reduction of the ubiquitin-protein ligase E3A enzyme. Angelman syndrome…”
    Get full text
    Journal Article
  5. 5

    Delta rhythmicity is a reliable EEG biomarker in Angelman syndrome: a parallel mouse and human analysis by Sidorov, Michael S, Deck, Gina M, Dolatshahi, Marjan, Thibert, Ronald L, Bird, Lynne M, Chu, Catherine J, Philpot, Benjamin D

    Published in Journal of neurodevelopmental disorders (08-05-2017)
    “…Clinicians have qualitatively described rhythmic delta activity as a prominent EEG abnormality in individuals with Angelman syndrome, but this phenotype has…”
    Get full text
    Journal Article
  6. 6

    The Interstitial Duplication 15q11.2-q13 Syndrome Includes Autism, Mild Facial Anomalies and a Characteristic EEG Signature by Urraca, Nora, Cleary, Julie, Brewer, Victoria, Pivnick, Eniko K., McVicar, Kathryn, Thibert, Ronald L., Schanen, N. Carolyn, Esmer, Carmen, Lamport, Dustin, Reiter, Lawrence T.

    Published in Autism research (01-08-2013)
    “…Chromosomal copy number variants (CNV) are the most common genetic lesion found in autism. Many autism‐associated CNVs are duplications of chromosome 15q…”
    Get full text
    Journal Article
  7. 7

    Angelman syndrome in adulthood by Larson, Anna M., Shinnick, Julianna E., Shaaya, Elias A., Thiele, Elizabeth A., Thibert, Ronald L.

    “…Angelman syndrome (AS) is a neurogenetic disorder. The goal of this study was to investigate the primary health issues affecting adults with AS and to further…”
    Get full text
    Journal Article
  8. 8

    A survey of seizures and current treatments in 15q duplication syndrome by Conant, Kerry D., Finucane, Brenda, Cleary, Nicole, Martin, Ashley, Muss, Candace, Delany, Mary, Murphy, Erin K., Rabe, Olivia, Luchsinger, Kadi, Spence, Sarah J., Schanen, Carolyn, Devinsky, Orrin, Cook, Edwin H., LaSalle, Janine, Reiter, Lawrence T., Thibert, Ronald L.

    Published in Epilepsia (Copenhagen) (01-03-2014)
    “…Summary Objective Seizures are common in individuals with duplications of chromosome 15q11.2‐q13 (Dup15q). The goal of this study was to examine the phenotypes…”
    Get full text
    Journal Article
  9. 9

    Understanding relationships between autism, intelligence, and epilepsy: a cross‐disorder approach by van EEGHEN, AGNIES M, PULSIFER, MARGARET B, MERKER, VANESSA L, NEUMEYER, ANN M, van EEGHEN, ELMER E, THIBERT, RONALD L, COLE, ANDREW J, LEIGH, FAWN A, PLOTKIN, SCOTT R, THIELE, ELIZABETH A

    Published in Developmental medicine and child neurology (01-02-2013)
    “…Aim  As relationships between autistic traits, epilepsy, and cognitive functioning remain poorly understood, these associations were explored in the…”
    Get full text
    Journal Article
  10. 10

    Epilepsy in Angelman syndrome: A questionnaire‐based assessment of the natural history and current treatment options by Thibert, Ronald L., Conant, Kerry D., Braun, Eileen K., Bruno, Patricia, Said, Rana R., Nespeca, Mark P., Thiele, Elizabeth A.

    Published in Epilepsia (Copenhagen) (01-11-2009)
    “…Summary Purpose:  Angelman syndrome (AS) commonly presents with epilepsy (>80%). The goal of this study was to examine the natural history and various…”
    Get full text
    Journal Article
  11. 11

    Hippocampal Abnormalities in Magnetic Resonance Imaging (MRI) of 15q Duplication Syndromes by Boronat, Susana, Mehan, William A., Shaaya, Elias A., Thibert, Ronald L., Caruso, Paul

    Published in Journal of child neurology (01-03-2015)
    “…Patients with 15q duplication syndromes, including isodicentric chromosome 15 and interstitial duplications, usually present with autism spectrum disorder,…”
    Get full text
    Journal Article
  12. 12

    The Use of Magnetic Resonance Spectroscopy in the Evaluation of Pediatric Patients With Seizures by Rincon, Sandra P., MD, Blitstein, Marisa B.K., MD, Caruso, Paul A., MD, González, R. Gilberto, MD, PhD, Thibert, Ronald L., DO, MsPH, Ratai, Eva-Maria, PhD

    Published in Pediatric neurology (01-05-2016)
    “…Abstract Background The objective was to determine if it is useful to routinely add magnetic resonance spectroscopy (MRS) to magnetic resonance imaging (MRI)…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Angelman syndrome genotypes manifest varying degrees of clinical severity and developmental impairment by Keute, Marius, Miller, Meghan T., Krishnan, Michelle L., Sadhwani, Anjali, Chamberlain, Stormy, Thibert, Ronald L., Tan, Wen-Hann, Bird, Lynne M., Hipp, Joerg F.

    Published in Molecular psychiatry (01-07-2021)
    “…Angelman Syndrome (AS) is a severe neurodevelopmental disorder due to impaired expression of UBE3A in neurons. There are several genetic mechanisms that impair…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Tolerability and dosing experience of intravenous levetiracetam in children and infants by Michaelides, Costas, Thibert, Ronald L, Shapiro, Michelle J, Kinirons, Peter, John, Tanya, Manchharam, Dipti, Thiele, Elizabeth A

    Published in Epilepsy research (01-10-2008)
    “…Summary Objective To evaluate the use and tolerability of intravenous (IV) levetiracetam (LEV) in a pediatric cohort under 14 years of age. Methods A…”
    Get full text
    Journal Article
  17. 17

    Reversible uncal herniation in a neonate with a large MCA infarct by Thibert, Ronald L, Burns, Joseph D, Bhadelia, Rafeeque, Takeoka, Masanori

    Published in Brain & development (Tokyo. 1979) (01-11-2009)
    “…Abstract Uncal herniation due to a large cerebral infarct is well-described in adults, with high rates of morbidity and mortality. This phenomenon, however,…”
    Get full text
    Journal Article
  18. 18

    Seizure treatment in Angelman syndrome: A case series from the Angelman Syndrome Clinic at Massachusetts General Hospital by Shaaya, Elias A, Grocott, Olivia R, Laing, Olivia, Thibert, Ronald L

    Published in Epilepsy & behavior (01-07-2016)
    “…Abstract Epilepsy is a common feature of Angelman syndrome (~ 80–90%), with the most common seizure types including myoclonic, atonic, atypical absence, focal,…”
    Get full text
    Journal Article
  19. 19

    If not Angelman, what is it? a review of Angelman-like syndromes by Tan, Wen-Hann, Bird, Lynne M., Thibert, Ronald L., Williams, Charles A.

    “…Angelman syndrome (AS) is caused by a lack of expression of the maternally inherited UBE3A gene in the brain. However, about 10% of individuals with a clinical…”
    Get full text
    Journal Article
  20. 20

    The STARS Phase 2 Study: A Randomized Controlled Trial of Gaboxadol in Angelman Syndrome by Bird, Lynne M., Ochoa-Lubinoff, Cesar, Tan, Wen-Hann, Heimer, Gali, Melmed, Raun D., Rakhit, Amit, Visootsak, Jeannie, During, Matthew J., Holcroft, Christina, Burdine, Rebecca D., Kolevzon, Alexander, Thibert, Ronald L.

    Published in Neurology (16-02-2021)
    “…To evaluate safety and tolerability and exploratory efficacy end points for gaboxadol (OV101) compared with placebo in individuals with Angelman syndrome (AS)…”
    Get full text
    Journal Article